Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance)
      Google Scholar   
Citation:
J. Clin. Oncol. vol 33 (suppl 3) abstr 306
Meeting Instance:
ASCO GI 2015
Year:
2015
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                   
Study
CALGB-80303
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: